Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: J Stone who wrote (27626)	1/27/1999 11:01:00 AM
From: bob zagorin	Read Replies (1) \| Respond to of 32384

for those of you tracking the Allergan arbitrage. Here's a line from their current Q report. just read the report quickly so someone might one to retrieve and look more closely. "... a one-time gain during the second quarter of $5.5 million related to the sale of Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) stock, and one-time gains during the third quarter of approximately $13 million from the sale of product rights and technology collaborations..."